Titre : Protéines intrinsèquement désordonnées

Protéines intrinsèquement désordonnées : Questions médicales fréquentes

Termes MeSH sélectionnés :

Case-Control Studies
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Protéines intrinsèquement désordonnées : Questions médicales les plus fréquentes", "headline": "Protéines intrinsèquement désordonnées : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Protéines intrinsèquement désordonnées : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-31", "dateModified": "2025-03-26", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Protéines intrinsèquement désordonnées" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Protéines", "url": "https://questionsmedicales.fr/mesh/D011506", "about": { "@type": "MedicalCondition", "name": "Protéines", "code": { "@type": "MedicalCode", "code": "D011506", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776" } } }, "about": { "@type": "MedicalCondition", "name": "Protéines intrinsèquement désordonnées", "alternateName": "Intrinsically Disordered Proteins", "code": { "@type": "MedicalCode", "code": "D064267", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Vladimir N Uversky", "url": "https://questionsmedicales.fr/author/Vladimir%20N%20Uversky", "affiliation": { "@type": "Organization", "name": "USF Health Byrd Alzheimer's Research Institute, Morsani College of Medicine, University of South Florida, Tampa, FL USA." } }, { "@type": "Person", "name": "Damiano Piovesan", "url": "https://questionsmedicales.fr/author/Damiano%20Piovesan", "affiliation": { "@type": "Organization", "name": "Department of Biomedical Sciences, University of Padova, Padova, Italy." } }, { "@type": "Person", "name": "Silvio C E Tosatto", "url": "https://questionsmedicales.fr/author/Silvio%20C%20E%20Tosatto", "affiliation": { "@type": "Organization", "name": "Department of Biomedical Sciences, University of Padova, Padova, Italy." } }, { "@type": "Person", "name": "Lukasz Kurgan", "url": "https://questionsmedicales.fr/author/Lukasz%20Kurgan", "affiliation": { "@type": "Organization", "name": "Department of Computer Science, Virginia Commonwealth University, Richmond, VA 23284, USA." } }, { "@type": "Person", "name": "Alexander Miguel Monzon", "url": "https://questionsmedicales.fr/author/Alexander%20Miguel%20Monzon", "affiliation": { "@type": "Organization", "name": "Department of Biomedical Sciences, University of Padova, Padova, Italy." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "A case-control study on immunologic markers of patients with vitiligo.", "datePublished": "2022-10-14", "url": "https://questionsmedicales.fr/article/36244264", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.biopha.2022.113785" } }, { "@type": "ScholarlyArticle", "name": "Case-Control Study of Long COVID, Sapporo, Japan.", "datePublished": "2023-04-12", "url": "https://questionsmedicales.fr/article/37044126", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3201/eid2905.221349" } }, { "@type": "ScholarlyArticle", "name": "Endothelium-biomarkers for postthrombotic syndrome: a case-control study.", "datePublished": "2023-03-29", "url": "https://questionsmedicales.fr/article/37016998", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/MBC.0000000000001192" } }, { "@type": "ScholarlyArticle", "name": "Risk Factors for Postoperative Pneumonia: A Case-Control Study.", "datePublished": "2022-07-08", "url": "https://questionsmedicales.fr/article/35875004", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fpubh.2022.913897" } }, { "@type": "ScholarlyArticle", "name": "Significance of temperature in antimuscarinic toxicity: a case-control study.", "datePublished": "2022-06-23", "url": "https://questionsmedicales.fr/article/35735006", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/15563650.2022.2088378" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines intrinsèquement désordonnées", "item": "https://questionsmedicales.fr/mesh/D064267" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Protéines intrinsèquement désordonnées - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Protéines intrinsèquement désordonnées", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Protéines intrinsèquement désordonnées", "description": "Comment diagnostiquer une maladie liée aux IDP ?\nQuels tests sont utilisés pour les IDP ?\nLes IDP peuvent-elles être détectées par imagerie ?\nY a-t-il des biomarqueurs pour les IDP ?\nLes tests génétiques aident-ils pour les IDP ?", "url": "https://questionsmedicales.fr/mesh/D064267?mesh_terms=Case-Control+Studies&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Protéines intrinsèquement désordonnées", "description": "Quels symptômes sont associés aux IDP ?\nLes IDP causent-elles des troubles neurologiques ?\nLes IDP sont-elles liées à des cancers ?\nPeut-on avoir des symptômes sans IDP ?\nLes IDP provoquent-elles des douleurs articulaires ?", "url": "https://questionsmedicales.fr/mesh/D064267?mesh_terms=Case-Control+Studies&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Protéines intrinsèquement désordonnées", "description": "Peut-on prévenir les maladies liées aux IDP ?\nL'alimentation influence-t-elle les IDP ?\nLe stress affecte-t-il les IDP ?\nL'exercice physique aide-t-il avec les IDP ?\nLes contrôles médicaux réguliers sont-ils importants ?", "url": "https://questionsmedicales.fr/mesh/D064267?mesh_terms=Case-Control+Studies&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Protéines intrinsèquement désordonnées", "description": "Comment traiter les maladies liées aux IDP ?\nY a-t-il des médicaments spécifiques pour les IDP ?\nLa thérapie génique aide-t-elle avec les IDP ?\nLes traitements naturels sont-ils efficaces pour les IDP ?\nLa physiothérapie aide-t-elle avec les IDP ?", "url": "https://questionsmedicales.fr/mesh/D064267?mesh_terms=Case-Control+Studies&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Protéines intrinsèquement désordonnées", "description": "Quelles complications peuvent survenir avec les IDP ?\nLes IDP peuvent-elles entraîner des maladies chroniques ?\nY a-t-il des risques de récidive avec les IDP ?\nLes IDP peuvent-elles affecter la qualité de vie ?\nLes IDP sont-elles liées à des troubles mentaux ?", "url": "https://questionsmedicales.fr/mesh/D064267?mesh_terms=Case-Control+Studies&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Protéines intrinsèquement désordonnées", "description": "Quels sont les facteurs de risque pour les IDP ?\nL'hérédité joue-t-elle un rôle dans les IDP ?\nL'exposition à des toxines influence-t-elle les IDP ?\nLe mode de vie affecte-t-il le risque d'IDP ?\nLes infections peuvent-elles être un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D064267?mesh_terms=Case-Control+Studies&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une maladie liée aux IDP ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests biochimiques et des analyses protéomiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour les IDP ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des techniques comme la spectroscopie RMN et la chromatographie sont courantes." } }, { "@type": "Question", "name": "Les IDP peuvent-elles être détectées par imagerie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Non, l'imagerie ne détecte pas directement les IDP, mais peut montrer des effets cellulaires." } }, { "@type": "Question", "name": "Y a-t-il des biomarqueurs pour les IDP ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Certaines IDP peuvent servir de biomarqueurs, mais cela reste en recherche." } }, { "@type": "Question", "name": "Les tests génétiques aident-ils pour les IDP ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les tests génétiques peuvent identifier des mutations, mais pas spécifiquement les IDP." } }, { "@type": "Question", "name": "Quels symptômes sont associés aux IDP ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes varient selon la maladie, incluant fatigue, douleurs et troubles neurologiques." } }, { "@type": "Question", "name": "Les IDP causent-elles des troubles neurologiques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines IDP sont liées à des maladies neurodégénératives comme Alzheimer." } }, { "@type": "Question", "name": "Les IDP sont-elles liées à des cancers ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Certaines IDP sont impliquées dans la régulation tumorale et peuvent favoriser le cancer." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes sans IDP ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, de nombreux symptômes peuvent être causés par d'autres facteurs non liés aux IDP." } }, { "@type": "Question", "name": "Les IDP provoquent-elles des douleurs articulaires ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Certaines maladies associées aux IDP peuvent entraîner des douleurs articulaires." } }, { "@type": "Question", "name": "Peut-on prévenir les maladies liées aux IDP ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention est difficile, mais un mode de vie sain peut réduire les risques." } }, { "@type": "Question", "name": "L'alimentation influence-t-elle les IDP ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut soutenir la santé cellulaire, mais ne prévient pas directement les IDP." } }, { "@type": "Question", "name": "Le stress affecte-t-il les IDP ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Le stress peut exacerber les symptômes, mais ne cause pas directement les IDP." } }, { "@type": "Question", "name": "L'exercice physique aide-t-il avec les IDP ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut améliorer la santé générale et réduire certains symptômes." } }, { "@type": "Question", "name": "Les contrôles médicaux réguliers sont-ils importants ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des contrôles réguliers peuvent aider à détecter précocement des problèmes liés aux IDP." } }, { "@type": "Question", "name": "Comment traiter les maladies liées aux IDP ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement dépend de la maladie spécifique et peut inclure médicaments et thérapies." } }, { "@type": "Question", "name": "Y a-t-il des médicaments spécifiques pour les IDP ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de médicaments spécifiques, mais des traitements ciblent les symptômes." } }, { "@type": "Question", "name": "La thérapie génique aide-t-elle avec les IDP ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie génique est en recherche pour certaines maladies liées aux IDP." } }, { "@type": "Question", "name": "Les traitements naturels sont-ils efficaces pour les IDP ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Certains traitements naturels peuvent soulager les symptômes, mais manquent de preuves solides." } }, { "@type": "Question", "name": "La physiothérapie aide-t-elle avec les IDP ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la physiothérapie peut aider à gérer les symptômes et améliorer la qualité de vie." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec les IDP ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des troubles neurologiques, des cancers et des maladies auto-immunes." } }, { "@type": "Question", "name": "Les IDP peuvent-elles entraîner des maladies chroniques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines IDP sont associées à des maladies chroniques comme la fibromyalgie." } }, { "@type": "Question", "name": "Y a-t-il des risques de récidive avec les IDP ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Certaines maladies liées aux IDP peuvent avoir des risques de récidive, selon le cas." } }, { "@type": "Question", "name": "Les IDP peuvent-elles affecter la qualité de vie ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les IDP peuvent gravement affecter la qualité de vie en raison des symptômes chroniques." } }, { "@type": "Question", "name": "Les IDP sont-elles liées à des troubles mentaux ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études suggèrent un lien entre IDP et troubles mentaux, mais les recherches continuent." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les IDP ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des prédispositions génétiques, l'âge et des facteurs environnementaux." } }, { "@type": "Question", "name": "L'hérédité joue-t-elle un rôle dans les IDP ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines IDP ont une composante héréditaire, augmentant le risque de maladies." } }, { "@type": "Question", "name": "L'exposition à des toxines influence-t-elle les IDP ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à certaines toxines peut augmenter le risque de maladies liées aux IDP." } }, { "@type": "Question", "name": "Le mode de vie affecte-t-il le risque d'IDP ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie malsain, comme le tabagisme, peut augmenter le risque de maladies liées aux IDP." } }, { "@type": "Question", "name": "Les infections peuvent-elles être un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections virales sont associées à un risque accru de maladies liées aux IDP." } } ] } ] }

Sources (10000 au total)

Endothelium-biomarkers for postthrombotic syndrome: a case-control study.

The postthrombotic syndrome (PTS) is a long-term complication of deep venous thrombosis (DVT). Increase knowledge on the PTS pathophysiology and novel biomarkers are needed in order to predict PTS dev... A case-control study was conducted. Inclusion criteria were symptomatic and confirmed DVT patients treated with anticoagulants for at least 3 months. Villalta score was performed at the time of inclus... Thirty two patients and 61 controls were included. PTS patients showed higher levels of CEC (0.56/μl (0.34-1.5) vs. 0.20/μl (0.11-0.77); P = 0.04) and EPC (0.75/μl (0.38-1.52) vs. 0.09/μl (0.05-0.82);... The formation and early resolution of DVT are characterized by inflammation and endothelial/platelet activation. We have identified possible novel biomarkers such as CEC, EPC and fractalkine for the d...

Risk Factors for Postoperative Pneumonia: A Case-Control Study.

Postoperative pneumonia is a preventable complication associated with adverse outcomes, that greatly aggravates the medical expenses of patients. The goal of our study is to identify risk factors and ... A matched 1:1 case-control study, including adult patients who underwent surgery between January 2020 and June 2020, was conducted in the Second Affiliated Hospital of Kunming Medical University in Ch... Out of 17,190 surgical patients, 264 (1.54%) experienced postoperative pneumonia. Increased age, chronic obstructive pulmonary disease, emergency surgery, postoperative reduced albumin, prolonged vent... Postoperative pneumonia is associated with severe clinical outcomes. We identified six independent risk factors that can aid in risk stratification and management of patients at risk of postoperative ... www.chictr.org.cn, identifier: chiCTR2100045986....

Significance of temperature in antimuscarinic toxicity: a case-control study.

Antimuscarinic toxicity can result in temperature dysregulation, but the clinical significance of this is unclear. The objective of this study was to compare peak temperatures between antimuscarinic p... This was a case-control analysis at two large, urban, academic medical centers from January 1, 2016, through December 31, 2021. We compared peak temperature (... Fifty-six patients met inclusion criteria of which 23 developed severe outcomes: 16 seizures, 9 cases with hypotension, 5 intubations, and 2 ventricular dysrhythmias. Tmax amongst all patients ranged ... Maximum temperatures did not differ between patients with and without severe outcomes in the setting of antimuscarinic toxicity, and temperature was poorly predictive of outcomes. Our findings suggest...

A postmortem case control study of asbestos burden in lungs of malignant mesothelioma cases.

Asbestos lung content is regarded as the most reliable tool for causal attribution of malignant mesothelioma (MM) to previous asbestos exposures. However, there is a lack of studies on asbestos burden... Asbestos lung content has been assessed on formalin-fixed lung fragments using scanning electron microscopy coupled with energy dispersion spectroscopy (SEM-EDS) on individuals deceased from MM (cases... Asbestos and asbestos bodies (ABs) were found, respectively, in 73.7% and 43.2% of cases and in 28 and 22% of controls; in MM cases the most represented asbestos types were crocidolite and amosite, wh... The results suggest a correlation between asbestos burden in lungs and MM risk. The different concentration of chrysotile, as well as the different width of asbestos fibers in MM males and females mig...

Anemia and Idiopathic Intracranial Hypertension: A Case-Control Study.

Idiopathic intracranial hypertension (IIH) is a condition that mostly affects obese women of childbearing age but has been reported to be temporally related to new diagnoses of anemia. Despite these r... Consecutive IIH patients were recruited from neuro-ophthalmology clinics and matched by age and sex to consecutive patients attending neuro-ophthalmology clinics with diagnoses other than IIH. Complet... One hundred twenty-three IIH patients and 113 controls were included in the study. More IIH patients than controls had anemia (22.8%, 28/123 vs 10.6%, 12/113, P = 0.01) with an odds ratio of 2.48 (95%... Idiopathic intracranial hypertension patients have a higher prevalence of anemia compared with non-IIH neuro-ophthalmology patients. The anemia was mostly mild and may be explained by other factors re...

Study on the association between adverse drug reactions to opioids and gene polymorphisms: a case-case-control study.

Adverse drug reactions (ADRs) caused by opioid drugs show individual differences. Our objective was to explore the association between gene polymorphism and ADRs induced by opioid drugs.... Evidence-based medical data analysis was conducted for genes related to ADRs induced by opioid drugs to select target genes. Sixty patients with cancer pain who had ADRs after taking opioid drugs (mor... Based on a database search and evidence-based medical data, we identified CYP2D6*10, CYP3A5*3, ABCB1, and OPRM1 as target genes for detection. The results of statistical analysis showed no significant... Polymorphism of ABCB1 (062rs1045642) is related to ADRs caused by oxycodone, and the incidence of ADRs is higher with the allele T. Polymorphism of ABCB1 is expected to become a clinical predictor of ...

Systemic hormone therapy and dementia: A nested case-control and co-twin control study.

The effect of systemic hormone therapy (HT) on dementia risk is unclear. Our aim was to investigate the association between HT and dementia.... This register-based study consists of a nested case-control study and a co-twin control design, which controls for familial confounding, including shared genetics.... Through Danish national registries from 1995 to 2011, we identified: a) 2700 female singletons with incident dementia and 13,492 matched controls; b) 288 female twins with incident dementia and co-twi... The odds ratio (OR) for the association between systemic HT and dementia was 1.05, 95% CI = [0.93-1.19] in singletons and 2.10, 95% CI = [0.99-4.46] in twins. A statistically significant association w... Using Danish nationwide registries and controlling for education and for familial factors in a subsample, systemic HT was found to be associated with increased dementia risk if used before 2003, when ...